PPT-Changing paradigms of hemophilia care across larger specialized treatment centers in the

Jerzy Windyga 1 Ana Boban 2 Irena Zupan 3 Niamh OConnell 4 Cedric Hermans 5 SELECTED HIGHLIGHTS 1 Laboratory of Hemostasis and Metabolic Diseases Department of Hemostasis Disorders and Internal Medicine Institute of Hematology and Transfusion Medicine Warsaw Poland . Whist eery eo rt is made to ensure accuracy there may be phonetic or other errors depending on ineitabe a riations in recording 0uaity Pease do contact us to point out any errors 1hich 1e 1i endeaour to co rrect To reproduce any part o this transcri Nairobi, Kenya. June 24, 2013. Objectives. Identify historical approaches used to treat hemophilia. Describe treatment products currently available for use in hemophilia. Distinguish classes of factor concentrates. A Social Sustainable Successful Initiative. About Ophilia CSR. Ophilia.  Bio - . O. means universal , . Philia. means family - Universal Family. . Ophilia.  also means Help in Greek. . The promoter of this entity believes that the aim of helping people globally is the possibility. The need to close the medical gap between developed and developing nation by co venturing with right set of partners to impact life. This brotherhood will create a community without borders and will foster a spirit of co-operating and co-creation rather then competitiveness and unbalanced growth. We want to provide a level playing field for people to experiences life in a positive way and create harmony. One way of doing this is meeting medical needs for people with orphan disease.. (. H. aemophilia). By: Morgan Dirienzo. The Royal Disease. Alternate Names and Symptoms. Some alternate names for Hemophilia would be Haemorrhaphilia, or Von Willebrand disease. . The Symptoms for Hemophilia are…. SUPPORTING THE DIALYSIS PATIENT IN TIMES OF DISASTER. What is dialysis? . Dialysis is a process of cleaning wastes and extra fluid from the blood artificially. . There are two major types of dialysis either Hemodialysis or Peritoneal Dialysis.. The DMAS “Safety Net”. Virginia Department of Medical Assistance Services (DMAS). October 2012. www.dmas.virginia.gov. 1. Department of Medical Assistance Services. What is EPSDT?. Early and Periodic Screening, Diagnosis and Treatment Program. More Than Factor Replacement Prescription. IDG. . Ugrasena. Hematology-oncology division . Child Health . Departement. of Dr. . Soetomo. Hospital - Faculty of Medicine . Airlangga. University. Gen D. Introduction/Overview. Introduction/Overview (cont). Importance of Prophylaxis, and Limitations on Its Application, in Hemophilia B. Key Unmet Need in Hemophilia B:. Reducing Patient Burden of Disease. . Peterson, Owen Comer, Quaevon Anderson, and Grace Hodges. Basic Information . Grace. . Hemophilia A. Classic hemophilia. Factor VIII deficiency. Hemophilia B. Christmas disease. Factor IX deficiency. A new ambition of the World Federation of Hemophilia. WFH Guidelines for the Management of Hemophilia. All recommendations are consensus based.. Srivastava A et al. Haemophilia. 2020;26(Suppl 6):1–158. . WVNHF. Amber Tichnell, Executive Director. Hemophilia and other bleeding disorders. The human body is made up of several clotting factors – Factors 1 through 13 plus Von . Willebrand. Factor. A person can have deficiencies in any of these factors. Robin Reid, MD. Clinical Director, Mary M Gooley Hemophilia Center. Hematologist and Medical Oncologist, Rochester Regional Health. July . 2021. Outline. History of the Mary M Gooley Hemophilia Treatment Center. Lizheng Shi, PhD, . MsPharm. Regents Professor and Interim Chair. Department of Health policy and Management. School of Public Health and Tropical Medicine. Funded by BioMarin Pharmaceutical, which provided input into study design.. Alfonso Iorio, MD PhD. McMaster University, Canada. Alfonso Iorio. MD, PhD, FRCPC. Professor of Medicine. McMaster University. Disclosures. McMaster University has received research, consultancy and educational funding for Population PK projects from Bayer, .